← back to search

Enfu Hui

University of California San Diego · US
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Lipid Membrane Structure and Behavior, and Cellular transport and secretion.
h-index
28
citations
6,423
works
61
NIH funding
primary concept
email

Recent publications

Functional differences between rodent and human PD-1 linked to evolutionary divergence
Science Immunology 2025cited by 29position: lastdoi
Orientation-dependent CD45 inhibition with viral and engineered ligands
Science Immunology 2024cited by 4position: middledoi
cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity
Immunity 2023cited by 95position: lastdoi
CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity
Nature Immunology 2023cited by 54position: middledoi
CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis
The Journal of Experimental Medicine 2023cited by 42position: lastdoi
<i>Cis</i> Interactions of Membrane Receptors and Ligands
Annual Review of Cell and Developmental Biology 2023cited by 16position: firstdoi
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
Immunity 2022cited by 342position: middledoi
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
Cell 2020cited by 185position: middledoi
PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
The Journal of Cell Biology 2020cited by 117position: lastdoi
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
Immunity 2019cited by 386position: lastdoi
TCR–pMHC bond conformation controls TCR ligand discrimination
Cellular and Molecular Immunology 2019cited by 35position: middledoi
Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
Cell Reports 2018cited by 191position: lastdoi
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
Science 2017cited by 1,649position: firstdoi
In vitro reconstitution of T cell receptor-mediated segregation of the CD45 phosphatase
Proceedings of the National Academy of Sciences 2017cited by 103position: middledoi
Phase separation of signaling molecules promotes T cell receptor signal transduction
Science 2016cited by 1,330position: middledoi
A Structural Role for the Synaptobrevin 2 Transmembrane Domain in Dense-Core Vesicle Fusion Pores
Journal of Neuroscience 2015cited by 53position: middledoi
In vitro membrane reconstitution of the T-cell receptor proximal signaling network
Nature Structural & Molecular Biology 2014cited by 157position: firstdoi
Synaptotagmin 7 functions as a Ca2+-sensor for synaptic vesicle replenishment
eLife 2014cited by 144position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yunlong Zhao · Tianjin University7 papers (2018–2025)Takeya Masubuchi · University of California San Diego6 papers (2020–2025)Xiaozheng Xu · University of California San Diego5 papers (2019–2023)Ronald D. Vale · University of California, San Francisco4 papers (2014–2017)Jack D. Bui · Moores Cancer Center4 papers (2019–2025)Jibin Zhang · Huazhong Agricultural University3 papers (2023–2025)Xiaolei Su · Yale University3 papers (2016–2017)Jun Huang · University of Chicago3 papers (2017–2019)Eric J. Bennett · University of California San Diego2 papers (2020–2022)Li‐Fan Lu · University of California San Diego2 papers (2019–2025)K. Christopher García · Tecnológico de Monterrey2 papers (2017–2024)Dibyendu K. Sasmal · Indian Institute of Technology Jodhpur2 papers (2017–2019)Calvin K. Lee · California NanoSystems Institute2 papers (2019–2023)Edwin R. Chapman · Howard Hughes Medical Institute2 papers (2014–2015)Christine Caron · University of California San Diego2 papers (2023–2025)Ira Mellman · Amgen (United States)2 papers (2017–2022) · 1 papers (2022–2022)Chia‐Hao Lin · University of California San Diego1 papers (2019–2019)Jane L. Grogan · Biogen (United States)1 papers (2022–2022)Nan Zhang · Qingdao University1 papers (2020–2020)